BCYC FY 2024 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$374M

FY 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$35M+30.8% YoY

Gross Profit

-$138M-390.3% margin

Operating Income

-$210M-595.0% margin

Net Income

-$169M-479.2% margin

EPS (Diluted)

$-2.90

Cash Flow

Operating Cash Flow

-$165M

Free Cash Flow

-$166M

Stock-Based Comp.

$38M

Balance Sheet

Total Assets

$957M

Total Liabilities

$164M

Stockholders' Equity

$793M

Cash & Equivalents

$880M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$35M	$27M	+30.8%
Gross Profit	-$138M	-$130M	-6.3%
Operating Income	-$210M	-$190M	-10.5%
Net Income	-$169M	-$181M	+6.4%